ORAI1 and renal cell carcinoma: The pharmacological characterization of SOCE in both N-EPCs and RCC-EPCs was further pursued by harnessing the biphasic sensitivity of Stim1/Orai1-mediated Ca2+ inrush to 2-APB [4], [55], [56].